Edwards Lifesciences | EW - Loan Capital


Edwards Lifesciences reported $600M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Artivion USD 215.35M 2.46M Mar/2026
AtriCure USD 61M 865K Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
ICU Medical USD 1.26B 4.09M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Masimo USD 445.7M 72.3M Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026